NHS England promoting new round of applications for practice pharmacists

NHS England promoting new round of applications for practice pharmacists

January 9 2018 NHS England is reminding health service providers that money is available for...

NMC expands options for demonstrating English language proficiency for overseas nursing staff

NMC expands options for demonstrating English language proficiency for overseas nursing staff

October 24 2017 New requirements regarding English language ability for nurses trained outside...

Funding bids invited for second phase of pharmacist recruitment for general practice

Funding bids invited for second phase of pharmacist recruitment for general practice

October 11 2017 General practices are being invited to apply for funding for the second round of...

RCP publishes guide for employing physician associates

RCP publishes guide for employing physician associates

September 26 2017 A new guide on physician associates sets out the role of the PA, their scope of...

  • NHS England promoting new round of applications for practice pharmacists

    NHS England promoting new round of applications for practice pharmacists

    Tuesday, 09 January 2018 11:58
  • NMC expands options for demonstrating English language proficiency for overseas nursing staff

    NMC expands options for demonstrating English language proficiency for overseas nursing staff

    Tuesday, 24 October 2017 16:03
  • Funding bids invited for second phase of pharmacist recruitment for general practice

    Funding bids invited for second phase of pharmacist recruitment for general practice

    Wednesday, 11 October 2017 13:34
  • RCP publishes guide for employing physician associates

    RCP publishes guide for employing physician associates

    Tuesday, 26 September 2017 15:55

adhdDecember 2 2015

Researchers have urged doctors to be cautious if considering prescribing methylphenidate for children or adolescents with attention deficit hyperactivity disorder (ADHD).

A Cochrane review has concluded that the drug may improve teacher-reported ADHD symptoms, teacher-reported general behaviour, and parent-reported quality of life among children and adolescents diagnosed with ADHD. “However, the low quality of the underpinning evidence means that we cannot be certain of the magnitude of the effects.”

The researchers assessed 38 parallel-group trials and 147 cross-over trials, representing over 12,200 patients, and found methylphenidate led to “modest” improvements in ADHD symptoms as a primary outcome. They also found there were improvements in general behaviour and quality of life. However, in all outcomes, the quality of the evidence was judged to be “very low”.

Data for serious adverse events was only reported in nine out of the 185 trials, meaning that while methylphenidate does not appear to be associated with an increased risk of serious adverse events, the quality of the evidence was again very low.

“It was apparent from assessing the included trials that it would have been possible for people involved in the trials to have been aware of which treatment the children were taking,” says Cochrane. “In addition, the reporting of results was not complete in many of the trials, and for some analyses there was variation among trial results.

“Based upon this information, the researchers urge clinicians to be cautious in prescribing methylphenidate, and to weigh up the benefits and risks more carefully.”

Professor Ole Jakob Storebø, a clinical psychologist from the Psychiatric Research Unit in Region Zealand, Denmark, led the team of 18 researchers carrying out the meta-analysis. “This review highlights the need for long-term, large, better-quality randomized trials so that we can determine the average effect of this drug more reliably,” he said.

Co-author Camilla Groth MD added: “This review shows very limited quality evidence for the effects of methylphenidate on children and adolescents with ADHD. Some might benefit, but we still don’t know which patients will do so. Clinicians prescribing methylphenidate must take account of the poor quality of the evidence, monitor treatment carefully, and weigh up the benefits and adverse effects.”

Links:

Cochrane announcement

Cochrane review summary

Ole Jakob Storebø et al. ‘Methylphenidate for children and adolescents with attention deficit hyperactivity disorder (ADHD)’. Cochrane Library. Published online November 25 2015.

Management News

February 23 2018 Health Education England has set out educational content expectations for nursing associates who administer medicines to patients.
February 20 2018 New British Thoracic Society guidelines on pleural mesothelioma include some key recommendations for primary care. The BTS guideline give recommendations and good practice points...